Form 4: Amgen Executive David M. Reese Reports Stock Disposal to Cover Tax Obligations

EVP & Chief Technology Officer of Amgen, David M. Reese, reports disposing of 768 shares of common stock on April 30, 2025, to cover tax obligations.

Summary

• On April 30, 2025, David M. Reese, EVP & Chief Technology Officer of Amgen Inc., reported a transaction involving the disposal of 768 shares of Amgen common stock.
• The transaction was executed to cover tax obligations, with the shares disposed of at a price of $288.56 per share.
• Following the transaction, Reese directly owns 39,934 shares of Amgen common stock, which includes 607 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports a routine stock disposal for tax purposes. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, such as officers and directors, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors for signals about a company's prospects.

Key Dates

Keywords

Amgen, David M. Reese, Stock Disposal, Form 4, Executive Compensation, Tax Obligations, Dividend Equivalents, AMGN